Objective To determine clinical manifestations, immunotherapy responsiveness and outcomes of glutamic acid decarboxylase-65 (GAD65) neurological autoimmunity. Methods We identified 323 Mayo Clinic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback